Cell Therapy Foundation 2018-04-11T16:25:03+00:00

Our Mission

The mission of Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education by advancing basic and applied knowledge, processes and therapies.

ADULT STEM CELLS are:

  • NOT embryonic or fetal stem cells

  • Ethical

  • Collected with no harm to the donor

  • Proven to be effective in a multitude of diseases

PROVEN SUCCESS

  • The clinical applications of adult stem cells are years ahead of embryonic, fetal, and induced pluripotent stem cell research

MSCs (Mesenchymal Stem Cells) can:

  • Decrease inflammation

  • Stimulate regeneration

  • Treat autoimmune disease by correcting the root cause

  • Be produced economically on a large scale

  • Be transplanted from one donor to another without the need for matching or immune suppression

Are Adult Stem Cells Safe?

To date there have been over 800 clinical applications of adult stem cell therapy showing safety and efficacy.

There are currently approximately 800 clinical trials involving the use of MSCs (mesenchymal stem cells) on clinicaltrials.gov, most of which involve the use of allogeneic (in which the donor and recipient are not the same person) adult stem cells, rather than autologous (in which the donor and recipient are the same person) adult stem cells — illustrating the broad safety characteristics of MSCs. Click here to read more.

Are Adult Stem Cells Effective?

We have seen many effective results from clinical trials as well as from countless patient testimonies offering real, world-based evidence. Click here to read more.

Picture of Arnold Caplan, PhD

Arnold Caplan, PhD at FDA/CBER Meeting in 2016

What do the experts say?

“The cell-based therapies being proposed and tested clinically in investigator-initiated trials are curative.”Arnold Caplan, PhD – Case Western Reserve University

Dr. Caplan is widely hailed as the “father of the mesenchymal stem cell”.  His comments were given at the FDA/CBER meeting for Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products in September, 2016.

Public Hearing before FDA/CBER (Food and Drug Administration/ Center for Biologics Evaluation and Research), “Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products,” 12 September 2016: (View Full Transcript)

Read More